In Vitro and Clinical Compassionate Use Experiences with the Drug-Repurposing Approach CUSP9v3 in Glioblastoma

Background: Glioblastoma represents the most common primary brain tumor in adults. Despite technological advances, patients with this disease typically die within 1–2 years after diagnosis. In the search for novel therapeutics, drug repurposing has emerged as an alternative to traditional drug devel...

Descripción completa

Detalles Bibliográficos
Autores principales: Halatsch, Marc-Eric, Dwucet, Annika, Schmidt, Carl Julius, Mühlnickel, Julius, Heiland, Tim, Zeiler, Katharina, Siegelin, Markus D., Kast, Richard Eric, Karpel-Massler, Georg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8708851/
https://www.ncbi.nlm.nih.gov/pubmed/34959641
http://dx.doi.org/10.3390/ph14121241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8708851/
https://www.ncbi.nlm.nih.gov/pubmed/34959641
http://dx.doi.org/10.3390/ph14121241

Ejemplares similares